Juan Fernando Ortiz

Juan Fernando Ortiz


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2025 in Coronary Artery Disease
Verified
Journal Article
Closed access
JOJuan Fernando Ortiz
Juan Fernando Ortiz
LFLuanna Paula Garcez de Carvalho Feitoza
Luanna Paula Garcez de Carvalho Feitoza
ALAna Yasmin Cáceres Lessa
Ana Yasmin Cáceres Lessa
JOJuliana Chaves de Oliveira
Juliana Chaves de Oliveira
LPLucas Chierici Pereira
Lucas Chierici Pereira
CGCamila Mota Guida
Camila Mota Guida
Background: Evidence from randomized studies support complete over culprit-only revascularization for patients with acute coronary artery syndrome (ACS) and multivessel coronary artery diseases (MVD). Whether these findings extend to elderly patients, however, has not been thoroughly explored. Methods: We conducted a systematic review and meta-analysis comparing clinical outcomes of elderly individuals (defined as age ≥75 years) with ACS and MVD submitted to complete vs partial-only percutaneous coronary intervention (PCI). PubMed, Embase, and Cochrane were searched. We computed pooled hazard ratios with 95% confidence intervals (CI) to preserve time time-to-event data. Results: We included 7 studies, of which 2 were RCT and 5 were multivariable adjusted cohorts, comprising a total 10 147, of whom 43.8% underwent complete revascularization. As compared with partial-only PCI, complete revascularization was associated with a lower all-cause mortality (hazard ratio 0.71; 95% CI 0.60–0.85; P < 0.01), cardiovascular mortality (hazard ratio 0.64; 95% CI 0.52–0.79; P < 0.01), and recurrent myocardial infarction (hazard ratio 0.65; 95% CI 0.50–0.85; P < 0.01). There was no significant difference between groups regarding the risk of revascularizations (hazard ratio 0.80; 95% CI 0.53–1.20; P = 0.28). Conclusion: Among elderly patients with ACS and multivessel CAD, complete revascularization is associated with a lower risk of all-cause mortality, cardiovascular mortality, and recurrent myocardial infarction.


21 January 2025 in Coronary Artery Disease
Verified
Journal Article
Closed access
JOJuan Fernando Ortiz
Juan Fernando Ortiz
MBMaria E. Benitez
Maria E. Benitez
ALAna Emanuel Coelho Pessoa Lima
Ana Emanuel Coelho Pessoa Lima
ALAlmir Alamino Lacalle
Almir Alamino Lacalle
GSGabriel Saad
Gabriel Saad
CGCamila Mota Guida
Camila Mota Guida
Long-term data are limited comparing percutaneous coronary intervention (PCI) with second-generation drug-eluting stents (S-DES) vs coronary artery bypass grafting (CABG) in patients with complex coronary artery disease (CAD). We aimed to conduct a systematic review and meta-analysis comparing these interventions in patients with left main or multivessel CAD. We systematically reviewed PubMed, Embase, and Cochrane for studies that compared PCI with S-DES and CABG in patients with left main or multivessel CAD with a minimum mean follow-up period of 3 years. Outcomes of interest were all-cause mortality, myocardial infarction (MI), stroke, and major adverse cardiovascular events (MACE). We extracted data from observational studies as multivariable-adjusted or propensity score-matched hazard ratio to minimize confounding and pooled hazard ratios with 95% confidence intervals (CIs) using a random effects model in Review Manager 5.4.1. We included 10 studies, 3 of which were randomized controlled trials, comprising a total of 26964 patients, of whom 14928 underwent PCI. As compared with CABG, S-DES had a significantly higher risk of all-cause mortality (hazard ratio 1.35; 95% CI 1.22–1.49; P < 0.001; I 2 = 0%), MACE (hazard ratio 1.27; 95% CI 1.08–1.50; P = 0.005; I 2 = 67%), and MI (hazard ratio 2.43; 95% CI 1.80–3.28; P < 0.01; I 2 = 0%). There was no significant difference between groups in incidence of stroke. In this meta-analysis of patients with complex CAD, PCI with S-DES was associated with an increased risk of mortality, MI, and MACE compared with CABG.